Dr. Daniel Aaron Grove, MD

Dr. Grove practices at MedStar Good Samaritan Hospital in Baltimore, Maryland, part of MedStar Health.

Dr. Grove's NPI, 1144406737, was assigned on January 14, 2008. Dr. Grove graduated from Emory School of Medicine in 2005. Dr. Grove holds Maryland license D76118.

Dr. Grove's primary practice is MedStar Good Samaritan Hospital, at 5601 Loch Raven Boulevard, Baltimore, MD 21239 in Baltimore City. The practice phone is (443) 444-3902.

Dr. Grove's primary practice is MedStar Good Samaritan Hospital in Baltimore, Maryland, part of MedStar Health. Dr. Grove is also affiliated with MedStar Union Memorial Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Grove to 1 more hospital, 3 group practices and clinics, 2 medical groups and 1 hospital outpatient department, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Grove practices, 7 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Grove's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Grove is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Grove's licenses on file in 3 states: Maryland, New Jersey and Georgia.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, pneumonia, pneumonia and respiratory infection, sleep apnea and tobacco use among the conditions Dr. Grove treats.

CMS data shows 773 Medicare services from Dr. Grove across 15 procedure codes in 2024, for 333 Medicare patients. Medicare paid $71,721 for them.

CMS counts 333 Medicare patients who saw Dr. Grove in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 38% are also on Medicaid. Their average risk score is 3.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Grove's median patient age at 64, with 56% women.

In 2024, Dr. Grove wrote 365 Medicare Part D claims for 76 patients. 39% of them were for generic drugs. CMS names the drug for 269 of them, across 13 drugs with 11 or more claims each, at $200,305 in total drug cost. In 2023, CMS named 244 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Grove for performance year 2024, reported as part of a group. Dr. Grove accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Grove as offering telehealth.

Dmand AI links 4 papers to Dr. Grove, published from 2020 to 2024. Dr. Grove's most frequent co-authors are Rabih Ibrahim Bechara, MD, David Matthew Berkowitz, MD and Ashik Pokharel.

CMS Open Payments shows 140 general payments to Dr. Grove from 22 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 96% of the total. GlaxoSmithKline, LLC. paid the most, $727.

Dmand AI lists 1 award for Dr. Grove, most recently CMS Stage 1 2012 in 2012.

Dr. Grove graduated from Emory School of Medicine in 2005.

Dr. Grove is in network with 16 carriers, including Aetna, United Healthcare and CareFirst BlueCross BlueShield. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.